This invention relates generally to a novel class of fused heterocyclic compounds of the Formula (I) or Formula (II):
1
or pharmaceutically acceptable salt forms thereof, which are inhibitors of trypsin-like serine protease enzymes, especially factor Xa, pharmaceutical compositions containing the same, and methods of using the same as anticoagulant agents for treatment and prevention of thromboembolic disorders.
本发明一般涉及公式(I)或公式(II)的新型融合
杂环化合物,或其药学上可接受的盐形式,这些化合物是胰
蛋白酶样
丝氨酸蛋白酶酶的
抑制剂,尤其是因子Xa,包含这些化合物的药物组合物,以及将其用作抗凝剂药物治疗和预防血栓栓塞性疾病的方法。